Patent · US Expired

Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors

US7560467B2 · kind B2 · utility

3Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 18, 2004
Grant dateJul 14, 2009
Priority date
Expiry dateFeb 5, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to indazolo-tetrahydropyrimidine-carboxamide derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such indazolo-tetrahydropyrimidine-carboxamide derivatives are useful in the treatment of diseases associated with inappropriate ROCK-1 kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.